Archives of Bone and Joint Surgery
Instructions for Authors
Table of Contents
To link to a section please click on any item in blue.
Examples of Appropriate Styling
Tables and charts
Literature review tables
Figure Legends and figures
Charge for Printing Color
Previously Published Figures or Tables
Current Concepts Review
Letters to the editor
Authors in Clinical Trials
Confidentiality of Patient Identity
Systematic Reviews and Meta-Analyses
Studies Involving Human Stem Cells and DNA Recombination
Last Update : 12/2019
This is a platinum open access journal archived in PubMed Central. Publication and archiving of articles is free of charge for authors. All related expenses are covered by a sponsor by the editorial office.
Papers are accepted for consideration on the understanding that their contents have not been published elsewhere or are currently under review at another journal (the copy right form), that they are of great importance to editorial revision and that the Editor-in-Chief is responsible for the order of publication. The Editors and Editorial Boards encourage submission of genuine clinical studies. Other manuscripts accepted for review include technical notes on instruments that are innovative or useful to surgeons and researchers, and papers describing unusual cases. Letters to the Editor should reference the title and publication date of the article discussed. Editorials are solicited by the editors; unsolicited editorials will be returned. The Editor-in-Chief is free from enforcement or conflict of any institution or companies for publishing preferences.
All papers submitted will be blinded of authors' names and origins and subject to screening before being peer-reviewed by Editorial Board members. Authors are requested to ensure that they have already submitted for ORCID number (click here for free ORCID submission: http://orcid.org/).
All SUBMISSIONS NOT MEETING THE REQUIREMENTS OUTLINED HERE WILL BE RETURNED TO THE CORRESPONDING AUTHOR FOR CORRECTION.
CAUTION: ABJS WILL REJECT AUTHORS THAT DO NOT EXECUTE THE ASKED CORRECTIONS BY THE EDITORIAL BOARD MORE THAN 4 TIMES.
Starting your submission
• Cover letter: must be in each submission stating that the manuscript has not been previously published in whole or in part or submitted elsewhere for review. Cover letter should be submitted through the submission website and indicate the reasons that the paper is suitable to be published in this journal.
• Manuscript: PDF file (PLEASE NOTE ALL REQUESTED PARAMETERS ABOUT PAPER PREPARATIONS ARE DONE).
(How to convert a Word document to a PDF? Click the File Button, click on or point to the arrow next to Save As, and then click PDF. In some versions, after clicking on save as, below the box, choose PDF in the drop-down menu of File Format, or in the Save as type list, click PDF. In the File Name list, type or select a name for the document.Choose the destination to save.Click Publish or Save)
• Figures: Each figure should be submitted separately. Acceptable format: JPEG, 300 dots per inch (DPI).
• Tables: all tables should be created in Microsoft Word using the Table function. Each table should be in a single file. Also all tables must have "Gridlines".
The corresponding author must be able to provide the following information at submission:
• Authors: first and last names, middle initial(s), degrees, postal addresses, telephone, and valid email addresses and ORCID ID for the first author and corresponding author.
• Manuscript detail information: title, abstract, running title, key words and Level of Evidence (these can be copied and pasted from your manuscript file)
• Name of institutional review board (IRB)/ethics committee or the human subjects assurance number, or an equivalent identifier must be included. For animal subject studies, name of local institutional animal care and use committee (IACUC) and the approval number or an equivalent identifier.
We highly recommend reviewing guidelines before preparing your scientific manuscript. Two valuable guidelines are the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_main. html) by the International Committee of Medical Journal Editors (ICMJE) and the EASE Guidelines for Authors and Translators of Scientific Articles to be Published in English (http://www.ease.org.uk/guidelines/index.shtml) by the European Association of Science Editors (EASE).
• Manuscripts must be prepared in English, Times New Romans font , font size: 12, double-spaced lines, continuous line numbering and margins should be set at 2.5 cm and left-hand justified only. All Lines and pages should be numbered, Page number at the bottom and center of the page. Inserting the Short Title in the header of page and Use Page Break to separate each section of Introduction, Methods, Results, Discussion, Conclusion, References, Figure Legends.
• Numbers: numbers less than 10 should be spelt, thus 5 should be written ‘five’. Numbers greater than 10 should be in Arabic numerals thus, 3,456 (not three thousand, four hundred and fifty six). It is better to avoid starting a sentence with a number.
• Measurements: Use SI metric units.
• Follow-up: In reporting results of surgery follow-up of less than one year is usually unacceptable.
• Title of the paper that should be short and succinct.
• Complete name(s) of author(s), followed by his/her highest academic degree(s).
• Institution where the work was done
• Authors' appointments
• Corresponding author’s name, mailing address, telephone and fax numbers, ORCID ID, and email address.
• 3 to 5 key words identifying the work
• All sources of financial and material support must be named. Like names of the granting organizations, applicable grant or contract numbers, names of each author who received funding material support.
• If any portion of the paper has been presented (not published), put a note in this section.
• Short running head of no more than 40 characters
Abstract:The manuscript must contain an abstract comprised of maximum 150 words for unstructured abstract (in review articles and case reports) and 250 words for structured abstract with sections like purpose, methods, results, conclusion (in original articles 450 words. Abstracts for clinical and laboratory studies should contain separate sections entitled Object (the goals of the study) and the last sentence of the abstract should describe the clinical relevance of the study, Methods (methods used to achieve the study goals), Results (results/findings of the study), and Conclusions (conclusions drawn from the work). If your paper contributes to a clinical trial, provide the registration number of the clinical trial and the name and URL of the registry where it can be found at the end of the Abstract.
Key Words :At the end of the abstract, authors should provide 3-5 key words for information retrieval. Key words should be taken from Medical Subject Headings (MeSH) from Index Medicus.
Level of evidence: Please define and add it after the keywords.
Main Text:Articles should be divided in order into Introduction, Methods, Results (or Summary of Cases), Discussion, and Conclusions. For more instructions see the section below.
Introduction: In here, state the purpose of the study reported, and summarize the rationale for the undertaking in a concise fashion.
Methods: This section should provide enough information for the reader to gain an understanding of the method(s) without reference to another work. Methods can be written in continuous prose with generous use of paragraphs or sub-headings. The following issues should be covered:
• Demographics of the patients or subjects
• Inclusion and exclusion criteria
• Study design
• Interventions, treatment
• Methods of measurement
• Document approval of the study by the local institutional review board (IRB) and state that informed consent was obtained.
• In case of interventional clinical trials, provide the registration number of the trial and the name and URL of the registry.
• No data or images revealing the identification of patients or healthy volunteers should be presented in the manuscript. If identifying data or images are deemed vital, a signed consent form from the patient/volunteer or person authorized to give consent, permitting publication in both print and electronic versions of the journal, must be available. The form can be downloaded from the (the patient consent form)
Results: In this section, concisely summarize the study findings. It is important to avoid including methods or discussion in the results section. The reader should be helped to see exactly what has happened, using a combination of text, tables, and figures. The expert advice of a statistician should be used. Good visual presentation is often the best way of making the data clear. Figures should look good and the legend should explain the figure without reference to the text. Often journals allow for supplementary data to be published online only—this is a useful way to publish large tables and additional figures.
Discussion: In this section, concisely emphasize major findings of the study and their significance. The hypothesis raised in the introduction should be considered in relation to the results obtained in the study. The discussion should explain why the results support the hypothesis and why they do not. It is important not to present actual results in the discussion. The results should be considered in relation to other published articles. It is important to identify the limitations of the study and to suggest directions for future research.
Conclusions: In this section, major findings of the study should be addressed and their potential clinical implications should be stated.
Acknowledgments: This section is a place to acknowledge individuals who have contributed to the study but do not meet the criteria for authorship. For example: photographers, data collectors, and literature editors. Contribution type of each individual should be specified.
Patient consent: A statement showing that informed consent was obtained from the study participant (patient or healthy volunteer) or, from the person authorized to give consent (like the guardian or next of kin).
Disclosure: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest by filling the ICMJE conflict of interest form (http://www.icmje.org/conflicts-of-interest/). If no conflict of interest exists, in the Disclosure section should be added to the manuscript with the following statement: “The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.” The corresponding author is responsible for the accuracy and completeness of the submitted information.
Please limit the number of references to 15 for Case reports, 10 for Letters to Editor, and 30 for the Original Papers. The first six author names should be listed. The following authors should be named as “et al”.
Note: et al. within the text should be italicized.
References should be inserted in parentheses, at the end of the sentence and before any colons and semi-colons and the full stop point: (2-4, 7).
We require you to numerate all references at the end of the related sentence in the text, and reference them numerically at the end. Abbreviations should be matched to the style of PubMed. If the references are not properly arranged, the manuscript will be returned to you for correction. Authors should avoid omitting rivals’ work, as well as over-referencing their own papers excessively
• According to our policy, we verify the accuracy of all references. If a reference is unavailable to us, we will contact the correspondence and request a copy for verification.To avoid delays in the publication of a manuscript, these requests must be answered in a timely fashion. If the author cannot provide the requested verification in 7 working days, the reference will be removed.
Standard Format for Journal Articles:
Author Surname Initials. Title of article. Title of journal (abbreviated form). Date (year only) of Publication: Volume Number(Issue Number): Page Numbers.
If the abbreviation is not stated, use the PubMed Journals Database to find your journal: http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals. The correct abbreviation will be listed.
Example: Kachooei AR, Ebrahimzadeh MH, Erfani-Sayyar R, Salehi M, Salimi E, Razi S. Short Form-McGill Pain Questionnaire-2 (SF-MPQ-2): A Cross-Cultural Adaptation and Validation Study of the Persian Version in Patients with Knee Osteoarthritis. Arch Bone Jt Surg. 2015 ;3(1):45-50.
Kachooei AR, Chase SM, Jupiter JB. Outcome Assessment after Aptis Distal Radioulnar Joint (DRUJ) Implant Arthroplasty. Arch Bone Jt Surg. 2014 ;2(3):180-4.
Standard Format for Books:
Author Surname Initials. Title: subtitle. Edition (if not the first). Place of publication:Publisher; Year.
Citing a whole book:
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL,Jameson JL, et al., editors. Harrison’s principles of internal medicine. 17th ed. New York:McGraw Hill; 2008.
Citing a Chapter in a book:
Alexander RG. Considerations in creating a beautiful smile. In: Romano R, editor. The art of the smile. London: Quintessence Publishing; 2005. p. 187-210.
Standard Format for Websites:
Author Surname Initials (if available). Title of Website [Internet]. Place of publication:Publisher; Date of First Publication [Date of last update; cited date]. Available from: URL
Vancouver Style requires the “Place of Publication”, the “Publisher” and the “Original Publication Date” as part of the citation. If these pieces of information are not given, use: [place unknown], [publisher unknown] or [date unknown].
Fehrenbach MJ. Dental hygiene education [Internet]. [Place unknown]: Fehrenbach and Associates; 2000 [updated 2009 May 2; cited 2009 Jun 15]. Available from: http://www.dhed.net/Main.html
Example: Skariah H. The tooth booth dental blog [Internet]. Mississauga (ON): Hans Skariah; 2004 -[cited 2009 Jun 20]. Available from: http://dentaldude.blogspot.com/
Tables and Charts: Should be created by Microsoft Word (using “Insert Table”). Tables must be editable; tables not editable will be returned. Each table should be submitted separately, named and addressed properly to the legend. The legends should be listed separately from the tables and figures. These should be clear and concise. It is important to have the correct number for the appropriate table or figure. Do not submit tables as part of the manuscript file. All tables should be cited in the text (They should be inserted in brackets: [Figure 1 and 2] [Figure 1; Table 2] . Provide a title for each table, and abbreviations used in tables must be addressed scientifically. Instructions are same for charts.
• Literature review tables should be listed from the left side, starting by first author’s last name, et al., and the publication date. References listed in a literature review table must also be addressed in the Reference section of the manuscript.
Figures: Figures and images of the radiologic studies should be reproduces in their best quality. Authors are responsible to provide high-resolution images. If images do not meet our requirements, we will return them and ask for higher quality.
File Requirements:Acceptable format is JPEG. If file compression needed make sure it is done in the best quality. Submit each figure separately and name it properly (i.e. Fig1.jpg). For figures containing more than one part, use letters.
Submission: Submit the figures as you are instructed on the website (link to the site)
Charge for Printing Color Figures:The current policy of the journal requires no charge for inclusion of black and white, or color figures in the print version of the paper.
Photographs and Graphs: Remove all information that reveals identification of study participants. If there is potential risk of identification, the participant must be informed and sign the patient consent form (link to patient consent form). y and x axis of the graphs should be addressed.
Cover Illustrations:Please provide a short legend for the cover picture submission. The Editor-in-chief chooses the cover image.
Original Figures:Authors should assign, transfer, all copyright ownership of previously unpublished figures to the ABJS by signing the Copyright form (link to copyright form).
Previously published figures and tables: Authors must ask for signed permission from the copyright owner to reproduce the figure or table, if they have already been published in another journal before.
Current Concepts Review: These should focus on a specific topic. Publication will be up the decision of the Editorial Board. Review articles should have a format that includes an abstract, introduction, body text, discussion, and a conclusion (or summary). The abstract must be written as one unstructured paragraph.
Clinical trials: ABJS endorses the CONSORT statement. The declaration of transparency should be made for each research article according to CONSORT checklist and statement. (Website: http://www.consort-statement.org/)
Case reports or technical notes:Case reports and technical notes should be no longer than 1,500 words. Case reports or technical notes require the body of the manuscript to be divided into 4 sections: Abstract, Introduction, Case Report(s) or Technical Notes, Discussion and conclusion. It is possible to follow guidance of CARE (for case reports) : http://www.care-statement.org/downloads/CAREchecklist-English.pdf
• The Abstract should not exceed 150 words, and must be written as one unstructured paragraph. In the Introduction, the reason for reporting the case or techniques should be stated in a clear and cohesive manner. The Case Report or Technical Note section should include relevant elements, such as patient history and treatment, or technical descriptions. Discussion should focus on the case or techniques and pertinent literature. References should not exceed 10.
Letters to the editor: Letters to AJBS accepted and edited at the Editor`s discretion will be published. Letters should reference the title and authors of the article they are in response to and should be no longer than 500 words with no more than 10 references. It must have an unstructured Abstract. Letters to the Editor will be sent to the article authors for response. It is the Editor-in-Chief`s final decision on whether Letters to the Editor and the response are published.
Case Illustrations, Literature Reviews, and Obituaries: An Abstract, Introduction, Methods section should be submitted. There is no word limit for these article types. We publish obituaries only from former editorial board members.
Note: All mentioned forms below, should be completed and submitted with the manuscript, as instructed in the Manuscript Preparation section.
Copyright Assignment: Copyright transfer form is to be completed by authors submitting manuscripts to the Journal of Archives of Bone & Joint Surgery. This form should be downloaded, printed and signed by the corresponding author on behalf of all authors and then uploaded while submission. The corresponding author is responsible for the accuracy and completeness of the submitted information.
Patient Consent: When there exist the risk for patients` identification to be revealed, author must ask for a signed permission from the study participant or responsible parent or guardian/next of kin.
Conflict of Interest Form: This form should be downloaded by Acrobat Reader software and be completed, no need to be printed for completing.
Review process: Scientific papers accepted for publication in scholarly journals are subject to peer review. For most journals this is an electronic process. Manuscripts are usually 4 reviewed by a minimum of two reviewers selected from a reviewer database according to specific expertise, the editorial board, PubMed and editorial choice. The reviewers are encouraged to complete the review within three weeks. The reviewers assess the paper’s suitability for publication against defined criteria. The reviewer is looking for a paper written with clarity in good English. It should be original and the conclusions supported by robust statistics and ethically sound data. The paper should present a coherent story. It is important that the paper fits the aims and scope of the journal. The journal’s Editor-in-Chief will make the final decision regarding publication, based upon the reviewer comments. Some consideration may be made to the article’s potential contribution to the impact factor and whether the paper is likely to be cited and downloaded. If the paper is not accepted for publication, a revision may be requested. It is important that authors review and respond to the recommendations made by the reviewers and the journal’s editor before resubmitting the article.
Notice: our editors adhere to the principles of the Singapore Declaration and the authoers are advised to familiarize with the statement:
Page proofs:The corresponding author will receive page proofs for final checking Authors may order reprints from the publisher at the time of printing. Orders submitted after the issue is printed are subject to considerably higher prices.
Time lines:After acceptance, Email will be sent to the author and time lines of the acceptance date and print date will be informed. The Editor-in-chief will decide when to publish a paper.
Publication process:After the editor has accepted a paper for publication, it is transferred electronically to the production office. Typically, the paper is copyedited and any minor errors in spelling and grammar are corrected. The paper is then typeset in the journal style and a proof of the paper is produced. The proofs are emailed to corresponding author to make corrections. The publisher checks all corrected papers and then they are uploaded onto the website of the ABJS journal.
• For ABJS, the papers will be freely accessible to all non-subscribers
• Manuscripts failing to meet the criteria discussed in this document will be returned to author.
• The editorial Board will shed light on the reasons why they decided to reject a manuscript and their points of view will be enclosed in an Email to the correspondence.
Articles that have been published shall remain exact and unaltered as far as is possible. However, circumstances may arise where an article is published that must later be retracted or removed. Such actions must not be undertaken lightly and can only occur under exceptional circumstances, such as:
Article Withdrawal: Used for Articles in press, which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Retraction: Infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like.
Article Removal: Legal limitations upon the publisher, copyright holder or author(s).
Article Replacement: Identification of false or inaccurate data that, if acted upon, would pose a serious health risk.
Authorship: We agree with the International Committee of Medical Journal Editors (ICMJE) that authorship should reflect all 4 of the following criteria:
• “Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work” AND
• “Drafting the article or revising it critically for important intellectual content” AND
• “Final approval of the version to be published” AND
• “Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.(http://www.icmje.org). Listed authors are held responsible for their contributions to the paper and must sign the Copyright Assignment form.
Group Authorship: In multi-central or multinational clinical trials, one or more investigators should be selected to represent the group, and take responsibilities of the contents. Authors also should meet all four criteria for authorship mentioned before. They all must sign the Copyright Assignment form. Use the phrase: “on behalf of the [name of the study group]” for each representative author. Write the other researchers names and affiliation in an appendix.
Authors in Clinical Trials: A disclosure must be stated by the author, for accessing to all data and their analysis, in studied that are sponsored by a drug manufacturing company or a surgical device producer. This disclosure should be submitted as a letter when the main manuscript is being submitted. Author should state that the manufacturer had no influence on what is reported in the manuscript.
Corresponding Author: The corresponding author holds and guarantees the transparency of the study. This person is the representative of all authors for communicating with the journal and the reviewers. In case of manuscript acceptance questions will be asked from this person regarding the study data and proofs, so it is vital for the correspondence to respond to the Emails in a timely manner.
Confidentiality of Patient Identity: No names, initials, dates of birth, or any clues that leads to identification of the patient or healthy volunteer should be revealed in the manuscript. This information could be as text, figures, imaging studies, or tables.
IRB Approval: In the Methods section of the manuscript you should state that the relevant institutional review board (IRB) or ethics committee approved the study protocol. The human subject identifier code should be presented to us.
Systematic Reviews and Meta-Analyses: Systemic reviews and meta-analyses should be provided according to the PRISMA statement (http://www.prisma statement.org/statement.htm) beforehand.
Studies Involving Human Stem Cells and DNA Recombinants: such Studies must follow the principles set in the Guidelines for Research Involving Recombinant DNA Molecules issued from the us national Institutes of health (http://grants.nih.gov/ grants/guide/notice-files/not-od-02-052.html). Authors should disclose clearly the protocol in the methods section.
Scientific misconduct: In any case of scientific misconduct, or the suspicion of this matter, the ABJS will forward that manuscript to an appropriate authority (like the authors’ institution) for investigation. After the investigation has been done, the ABJS will act (such as retraction of a published article if scientific misconduct is proven).
Plagiarism: We strongly recommend submissions of works that have not been published before. We check for plagiarism and duplication (https://www.doccop.com/index.html) . If such duplicate publication or plagiarism exists, authors must notify the Editor-in-chief when submitting their manuscript. The accepted threshold for this journal is upto 15% and more than this percent is not acceptable. All contents should provide clear reference to the previous work. Use quotation marks for addressing to an identical work or others. Paraphrase or quote as long as the original work is referenced. For longer quotations, the author should ask permission from the copyright. (ABJS will execute further steps in case of any conflicts according to the COPE flowcharts. http://publicationethics.org/resources/flowcharts)
Archives of Bone and Joint Surgery Group, Ahmadabad Blvd, Ghaem Medical Center and Teaching Hospital, Mashhad, Iran
Tel-Fax : +985138417453
قابل توجه نویسندگان فارسی زبان: با توجه به اینکه این مجله حمایت مالی چندانی از طرف دانشگاه علوم پزشکی مشهد و یا وزارت بهداشت ندارد، براساس مصوبه شورای سردبیری، مقرر شده است هزینه انتشار مقالات؛ معادل 450 هزار تومان به ازاء هر صفحه بابت page design, proof editing و ... اخذ شود.
این مبلغ به حساب مشترک متعلق به مجله نزد بانک آینده که به نام محمدحسین ابراهیم زاده، امیررضا کچویی و یاس عرفانی هست واریز می شود.
لطفاً فرم مربوطه تکمیل و اپلود شود. Publishing Cost Agreement